Press Releases | Greenwich LifeSciences, Inc. (GLSI) | GP2

Oct 02, 2025 6:00am EDT

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium

Sep 30, 2025 6:00am EDT

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

Sep 18, 2025 6:00am EDT

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland

Sep 10, 2025 6:00am EDT

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation

Aug 20, 2025 9:25am EDT

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

Aug 19, 2025 6:00am EDT

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team

Aug 13, 2025 6:00am EDT

Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania

Aug 11, 2025 6:00am EDT

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

Apr 03, 2025 8:00am EDT

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Apr 02, 2025 6:00am EDT

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

1
2
3
4
5
6
7
8
9
10
Next